Legal Representation
Attorney
Janina Gorbach
USPTO Deadlines
Next Deadline
134 days remaining
NOA E-Mailed - SOU Required
Due Date
May 05, 2026
Extension Available
Until November 05, 2026
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 27, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 26, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 26, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 26, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 10, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 10, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 9, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 9, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 5, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 10, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 10, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 21, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 8, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 7, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 30, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
Classification
International Classes
005